IP Library Granted Patent US 7,482,172
Granted Patent B2
US 7,482,172 · App. 11/229,960 · Granted Jan 27, 2009

Peptides for discrimination of prions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,482,172
App. No.
11/229,960
Granted
Jan 27, 2009
Kind
B2
Abstract

The aim of the present invention is to provide a non-intrusive way to isolate, concentrate and monitor the TSE disease-related pathogenic prion protein. The invention described several peptides and their ability to capture PrP Sc from brain homogenate of prion disease infected animal and human. These eight peptides do not capture cellular prion protein from individual with no prion disease.

Claims (8)

1. A kit for the detection of PrP Sc comprising:

a solid support having bound thereto peptide selected from the group consisting of: (SEQ ID No.: 1) WQPPRARI; (SEQ ID No.: 2) NWCKRGRKQCKTH; (SEQ ID No.: 3) NYKKPKL; (SEQ ID No.: 5) YRGYRGYRGYRG; (SEQ ID No.: 6) YRGRYGYKGKYGYRG; (SEQ ID No.: 7) AQKKDGKKRKRSRKESYSIYV; (SEQ ID No.: 8) ARTKQTARKSTGGKSPRKQLA; and (SEQ ID No.: 9) SGRGKGGKGLGKGGAKRHRKVLR, and

a labeled prion specific antibody,

wherein the peptide specifically captures PrP Sc and the labeled prion specific antibody detects the captured PrP Sc .

2. A kit for the detection of PrP Sc comprising:

a solid support having bound thereto a prion specific antibody, and

a labeled peptide selected from the group consisting of: (SEQ ID No.: 1) WQPPRARI; (SEQ ID No.: 2) NWCKRGRKQCKTH; (SEQ ID No.: 3) NYKKPKL; (SEQ ID No.: 5) YRGYRGYRGYRG; (SEQ ID No.: 6) YRGRYGYKGKYGYRG; (SEQ ID No.: 7) AQKKDGKKRKRSRKESYSIYV; (SEQ ID No.: 8) ARTKQTARKSTGGKSPRKQLA; and (SEQ ID No.: 9) SGRGKGGKGLGKGGAKRHRKVLR

wherein the prion specific antibody captures PrP C and PrP Sc and the labeled peptide specifically detects the captured PrP Sc .

Assignments (5)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →